Synthetic peptide (P-21) derived from Asp-hemolysin inhibits the induction of apoptosis on HUVECs by lysophosphatidylcholine

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 5, 2006, Pages 907-910

  Tsutsumi, Hiromu ^a   Kumagai, Takeshi ^a   Naitoo, Saori ^a   Ebina, Keiichi ^a   Yokota, Katsushi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Asp hemolysin related peptide; Binding; Lysophosphatidylcholine

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; HEMOLYSIN; LIPOCORTIN 5; LYSOPHOSPHATIDYLCHOLINE; PROPIDIUM IODIDE; PROTEIN P21; SYNTHETIC PEPTIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; DRUG SYNTHESIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN INTERACTION;

ANNEXIN A5; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; OXIDATION-REDUCTION; PROTEIN BINDING;

EID: 33646451959     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.907     Document Type: Article

References (27)

1. Scandinavian Simvastatin Survival Study Group, Lancet, 344, 1383-1389 (1994).
2. Steinberg D., J. Biol. Chem., 272, 20936-20966 (1997).
3. Yla-Herttualä S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S. W., Witztum J. L., Steinberg D., J. Clin. Invest., 84, 1086-1095 (1989).
4. Kugiyama K., Kerns S. A., Morrisett J. D., Roberts R., Henry P. D., Nature (London), 344, 215-218 (1990).
5. Escargueli-Blanc I., Meilhac O., Pieraggi M.-T., Arnal J.-F., Salvayre R., Negre-Salvayre A., Arterioscler. Thromb. Vasc. Biol., 17, 331-339 (1997).
6. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D., Proc. Natl. Acad. Sci. U.S.A., 81, 3883-3887 (1984).
7. Sata M., Walsh K., J. Biol. Chem., 273, 33103-33106 (1998).
8. Yokota K., Shimada H., Kamaguchi A., Sakaguchi O., Microbiol. Immunol., 21, 11-22 (1977).
9. Ebina K., Sakagami H., Yokota K., Kondo H., Biochim. Biophys. Acta, 1219, 148-150 (1994).
10. Kudo Y., Fukuchi Y., Kumagai T., Ebina K., Yokota K., Biochim. Biophys. Acta, 1568, 183-188 (2001).
11. Kudo Y., Ootani T., Kumagai T., Fukuchi Y., Ebina K., Yokota K., Biol. Pharm. Bull., 25, 787-790 (2002).
12. Kumagai T., Ogawa N., Tsutsumi H., Ebina K., Yokota K., Biol. Pharm. Bull., 28, 1381-1384 (2005).
13. Havel R. J., Eder H. A., Bragdon J. H., J. Clin. Invest., 34, 1345-1353 (1995).
14. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
15. Yagi K., Biochem. Med., 15, 212-216 (1976).
16. Soini E., Kojila H., Clin. Chem., 29, 65-68 (1983).
17. Kusuhara M., Chait A., Cader A., Berk B. C., Arterioscler. Thromb. Vasc. Biol., 17, 141-148 (1997).
18. Berliner J. A., Heinecke J. W., Free Radic. Biol. Med., 20, 707-727 (1996).
19. Nishi E., Kume N., Ueno Y., Ochi H., Morikawa H., Kita T., Circ. Res., 83, 508-515 (1998).
20. Ochi H., Kume N., Nishi E., Morikawa H., Masuda M., Fujikawa K., Kita T., Biochem. Biophys. Res. Commun., 243, 862-868 (1998).
21. Kume N., Gimbrone M. A. Jr., J. Clin. Invest., 93, 907-911 (1994).
22. Chien-Cheng H., Mao-Hsiung Y., Hwan-Wun L., Ying-Tung L., Atherosclerosis, 151, 481-491 (2000).
23. Geng Y. J., Libby P., Am. J. Pathol., 147, 251-266 (1995).
24. Phoebe L., Richard D. Y., J. Biol. Chem., 278, 14379-14386 (2002).
25. Salvayre R., Auge N., Benoist H., Negre-Salvayre A., Biochim. Biophys. Acta, 1585, 213-221 (2002).
26. Ross R., N. Engl. J. Med., 340, 115-126 (1999).
27. Tricot O., Mallat Z., Heymes C., Belmin J., Leaseche G., Tedgui A., Circulation, 101, 2450-2453 (2000).